RXRX logo

RXRX Current liabilities

annual current liabilities:

$187.47M+$94.30M(+101.21%)
December 31, 2024

Summary

  • As of today (July 4, 2025), RXRX annual total current liabilities is $187.47 million, with the most recent change of +$94.30 million (+101.21%) on December 31, 2024.
  • During the last 3 years, RXRX annual current liabilities has risen by +$140.81 million (+301.80%).
  • RXRX annual current liabilities is now at all-time high.

Performance

RXRX Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXbalance sheet metrics

quarterly current liabilities:

$141.98M-$45.49M(-24.27%)
March 31, 2025

Summary

  • As of today (July 4, 2025), RXRX quarterly total current liabilities is $141.98 million, with the most recent change of -$45.49 million (-24.27%) on March 31, 2025.
  • Over the past year, RXRX quarterly current liabilities has increased by +$68.06 million (+92.07%).
  • RXRX quarterly current liabilities is now -24.27% below its all-time high of $187.47 million, reached on December 31, 2024.

Performance

RXRX quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

RXRX Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+101.2%+92.1%
3 y3 years+301.8%+65.7%
5 y5 years+2704.8%-

RXRX Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+301.8%-24.3%+92.1%
5 y5-yearat high+2704.8%-24.3%+514.7%
alltimeall timeat high+2704.8%-24.3%+514.7%

RXRX Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$141.98M(-24.3%)
Dec 2024
$187.47M(+101.2%)
$187.47M(+72.2%)
Sep 2024
-
$108.89M(+26.5%)
Jun 2024
-
$86.08M(+16.5%)
Mar 2024
-
$73.92M(-20.7%)
Dec 2023
$93.17M(-7.1%)
$93.17M(-1.0%)
Sep 2023
-
$94.12M(-17.4%)
Jun 2023
-
$113.96M(+23.7%)
Mar 2023
-
$92.15M(-8.1%)
Dec 2022
$100.27M
$100.27M(+20.7%)
DateAnnualQuarterly
Sep 2022
-
$83.04M(-14.1%)
Jun 2022
-
$96.65M(+12.8%)
Mar 2022
-
$85.70M(+83.7%)
Dec 2021
$46.66M(+102.0%)
$46.66M(+8.7%)
Sep 2021
-
$42.94M(+45.4%)
Jun 2021
-
$29.54M(+10.0%)
Mar 2021
-
$26.85M(+16.3%)
Dec 2020
$23.10M(+245.6%)
-
Dec 2020
-
$23.10M
Dec 2019
$6.68M
-

FAQ

  • What is Recursion Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals annual current liabilities year-on-year change?
  • What is Recursion Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals quarterly current liabilities year-on-year change?

What is Recursion Pharmaceuticals annual total current liabilities?

The current annual current liabilities of RXRX is $187.47M

What is the all time high annual current liabilities for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high annual total current liabilities is $187.47M

What is Recursion Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, RXRX annual total current liabilities has changed by +$94.30M (+101.21%)

What is Recursion Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of RXRX is $141.98M

What is the all time high quarterly current liabilities for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high quarterly total current liabilities is $187.47M

What is Recursion Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, RXRX quarterly total current liabilities has changed by +$68.06M (+92.07%)
On this page